Načítá se...
A Review of the Clinical Pharmacokinetics of Polymyxin B
Polymyxin B remains an antibiotic of last resort because of its toxicities. Although newer therapies are becoming available, it is anticipated that resistance to these agents will continue to emerge, and understanding the safest and most efficacious manner to deliver polymyxin B will remain highly i...
Uloženo v:
| Vydáno v: | Antibiotics (Basel) |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6466567/ https://ncbi.nlm.nih.gov/pubmed/30909507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics8010031 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|